Evaluation of the diagnostic performance of the rapid test VIKIA HIV1/2 in a highly complex HIV-1 epidemic

Ângela Santos; Sofia Clemente; Inês Bártolo; Claudia Palladino; Patrícia Cavaco-Silva; Verónica Franco; Marta Epalanga; Rui Pinto; Nuno Taveira

doi:10.1016/j.diagmicrobio.2011.06.002

Evaluation of the diagnostic performance of the rapid test VIKIA HIV1/2 in a highly complex HIV-1 epidemic

Ângela Santos
, Sofia Clemente
, Inês Bártolo
, Claudia Palladino
, Patrícia Cavaco-Silva
, Verónica Franco
, Marta Epalanga
, Rui Pinto
, Nuno Taveira

Research output: Contribution to journal › Article › peer-review

6 Citations (Scopus)

Abstract

The rapid test VIKIA HIV1/2 was evaluated in 210 Angolan subjects infected with multiple HIV-1 subtypes and complex recombinant forms and 225 seronegative individuals. All infected subjects tested positive (100% sensitivity); all seronegative subjects tested negative (100% specificity). VIKIA HIV1/2 is highly specific and sensitive even in highly complex epidemics.

Original language	English
Pages (from-to)	90-92
Number of pages	3
Journal	Diagnostic Microbiology and Infectious Disease
Volume	71
Issue number	1
DOIs	https://doi.org/10.1016/j.diagmicrobio.2011.06.002
Publication status	Published - Sept 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Clinical sensitivity and specificity
HIV-1 genetic forms
Rapid diagnosis of HIV-1 infection in Angola
VIKIA HIV1/2

Access to Document

10.1016/j.diagmicrobio.2011.06.002

Cite this

@article{8d3a935f04d24f3db022dfca6fad12b1,

title = "Evaluation of the diagnostic performance of the rapid test VIKIA HIV1/2 in a highly complex HIV-1 epidemic",

abstract = "The rapid test VIKIA HIV1/2 was evaluated in 210 Angolan subjects infected with multiple HIV-1 subtypes and complex recombinant forms and 225 seronegative individuals. All infected subjects tested positive (100\% sensitivity); all seronegative subjects tested negative (100\% specificity). VIKIA HIV1/2 is highly specific and sensitive even in highly complex epidemics.",

keywords = "Clinical sensitivity and specificity, HIV-1 genetic forms, Rapid diagnosis of HIV-1 infection in Angola, VIKIA HIV1/2",

author = "{\^A}ngela Santos and Sofia Clemente and In{\^e}s B{\'a}rtolo and Claudia Palladino and Patr{\'i}cia Cavaco-Silva and Ver{\'o}nica Franco and Marta Epalanga and Rui Pinto and Nuno Taveira",

note = "Funding Information: This work was supported by Funda{\c c}{\~a}o GlaxoSmithKline para as Ci{\^e}ncias da Sa{\'u}de, Portugal; Funda{\c c}{\~a}o para a Ci{\^e}ncia e Tecnologia (project PTDCSAU-FCF6767/2006 ), Portugal; and CHAIN (Collaborative HIV and Anti-HIV Drug Resistance Network), European Union . In{\^e}s B{\'a}rtolo is supported by a PhD grant from Funda{\c c}{\~a}o para a Ci{\^e}ncia e Tecnologia . Claudia Palladino is supported by The Spanish MICINN through the Juan de la Cierva program ( JCI-2009-05650 ). ",

year = "2011",

month = sep,

doi = "10.1016/j.diagmicrobio.2011.06.002",

language = "English",

volume = "71",

pages = "90--92",

journal = "Diagnostic Microbiology and Infectious Disease",

issn = "0732-8893",

publisher = "Elsevier Inc.",

number = "1",

}

TY - JOUR

T1 - Evaluation of the diagnostic performance of the rapid test VIKIA HIV1/2 in a highly complex HIV-1 epidemic

AU - Santos, Ângela

AU - Clemente, Sofia

AU - Bártolo, Inês

AU - Palladino, Claudia

AU - Cavaco-Silva, Patrícia

AU - Franco, Verónica

AU - Epalanga, Marta

AU - Pinto, Rui

AU - Taveira, Nuno

N1 - Funding Information: This work was supported by Fundação GlaxoSmithKline para as Ciências da Saúde, Portugal; Fundação para a Ciência e Tecnologia (project PTDCSAU-FCF6767/2006 ), Portugal; and CHAIN (Collaborative HIV and Anti-HIV Drug Resistance Network), European Union . Inês Bártolo is supported by a PhD grant from Fundação para a Ciência e Tecnologia . Claudia Palladino is supported by The Spanish MICINN through the Juan de la Cierva program ( JCI-2009-05650 ).

PY - 2011/9

Y1 - 2011/9

N2 - The rapid test VIKIA HIV1/2 was evaluated in 210 Angolan subjects infected with multiple HIV-1 subtypes and complex recombinant forms and 225 seronegative individuals. All infected subjects tested positive (100% sensitivity); all seronegative subjects tested negative (100% specificity). VIKIA HIV1/2 is highly specific and sensitive even in highly complex epidemics.

AB - The rapid test VIKIA HIV1/2 was evaluated in 210 Angolan subjects infected with multiple HIV-1 subtypes and complex recombinant forms and 225 seronegative individuals. All infected subjects tested positive (100% sensitivity); all seronegative subjects tested negative (100% specificity). VIKIA HIV1/2 is highly specific and sensitive even in highly complex epidemics.

KW - Clinical sensitivity and specificity

KW - HIV-1 genetic forms

KW - Rapid diagnosis of HIV-1 infection in Angola

KW - VIKIA HIV1/2

UR - https://www.scopus.com/pages/publications/80051663920

U2 - 10.1016/j.diagmicrobio.2011.06.002

DO - 10.1016/j.diagmicrobio.2011.06.002

M3 - Article

C2 - 21798684

AN - SCOPUS:80051663920

SN - 0732-8893

VL - 71

SP - 90

EP - 92

JO - Diagnostic Microbiology and Infectious Disease

JF - Diagnostic Microbiology and Infectious Disease

IS - 1

ER -

Evaluation of the diagnostic performance of the rapid test VIKIA HIV1/2 in a highly complex HIV-1 epidemic

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this